Skip to main content
OpenTrials

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

200 public trials 80 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Recruiting

Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi

NCT05929222

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Nuovo Ospedale Civile di Sassuolo - Day Hospital Oncologico Sassuolo, Modena (MO), Italy
  • Azienda Ospedaliera Nazionale Ss Antonio E Biagio E C Arrigo, SCDU Ematologia Alessandria, Italy
  • AORN San Giuseppe Moscati Avellino, U.O.C. Ematologia e Trapianto Emopoietico Avellino, Italy
  • Centro Di Riferimento Oncologico Di Aviano, S.O.C. Oncologia Medica e dei Tumori Immunocorrelati Aviano, Italy
View all 49 locations
View Trial Details
Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

NCT07211178

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Birmingham Hematology Associates Birmingham, Alabama, United States
  • PIH Health Whittier Hospital Whittier, California, United States
  • Cleveland Clinic Florida Weston, Florida, United States
  • Southern Illinois Hospital Services Carbondale, Illinois, United States
View all 16 locations
View Trial Details
Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

NCT05868226

Conditions
Adenocarcinoma, Adenocarcinoma of Colon, Breast Diseases, +51 more
Locations
  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
View Trial Details
Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

NCT06500273

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
  • Alta Bates Summit Medical Center Berkeley, California, United States
  • City of Hope Duarte, California, United States
View all 83 locations
View Trial Details
Recruiting

Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML

NCT05904106

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Universitätsklinikum Essen Essen, North Rhine-Westphalia, Germany
  • Universitätsklinikum Aachen Aachen, Germany
  • Universitätsklinikum Augsburg Augsburg, Germany
  • Klinikum Chemnitz gGmbH Chemnitz, Germany
View all 18 locations
View Trial Details

Related conditions